SYNTARGA BV has a total of 60 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), Australia and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are RPG LIFE SCIENCES LTD, UNI PHARMA KLEON TSETIS PHARMACEUTICAL LAB SA and NFLECTION THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 9 | |
#2 | Australia | 8 | |
#3 | Canada | 8 | |
#4 | United States | 6 | |
#5 | WIPO (World Intellectual Property Organization) | 6 | |
#6 | China | 4 | |
#7 | Hungary | 4 | |
#8 | Republic of Korea | 4 | |
#9 | Brazil | 3 | |
#10 | Japan | 3 | |
#11 | Mexico | 3 | |
#12 | Ukraine | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Peptides | |
#5 | Nanostructure applications | |
#6 | Sugars | |
#7 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Beusker Patrick Henry | 56 |
#2 | Joosten Johannes Albertus Frederikus | 42 |
#3 | Spijker Henri Johannes | 42 |
#4 | De Groot Franciscus Marinus Hendrikus | 36 |
#5 | Coumans Rudy Gerardus Elisabeth | 31 |
#6 | Elgersma Ronald Christiaan | 30 |
#7 | Menge Wiro Michael Petrus Bernardus | 23 |
#8 | Scheeren Johannes Wilhelm | 9 |
#9 | Menge Wiro Michaël Petrus Bernardus | 8 |
#10 | Major Felix | 7 |
Publication | Filing date | Title |
---|---|---|
US2015216844A1 | Substituted CC-1065 analogs and their conjugates | |
KR20170027880A | Novel conjugates of cc-1065 analogs and bifunctional linkers | |
HUE035798T2 | Cc-1065 analogs and their conjugates | |
EP2173739A1 | Substituted cc-1065 analogs and their conjugates | |
MX2008009956A | Water-soluble cc-1065 analogs and their conjugates. | |
AU2006277117A1 | Triazole-containing releasable linkers and conjugates comprising the same | |
WO2004043493A1 | Prodrugs built as multiple self-elimination-release spacers | |
EP1370298A1 | Elongated and multiple spacers in activatible prodrugs |